Phenotype
|
Fish
|
Conditions
|
Figures
|
whole organism viability, abnormal
|
AB + MO1-ptgs1
|
standard conditions
|
Fig. 5
from Grosser et al., 2002
|
epiboly involved in gastrulation with mouth forming second delayed, abnormal
|
AB + MO1-ptgs1
|
standard conditions
|
Fig. 5
from Grosser et al., 2002
|
pronephric distal late tubule size, ameliorated
|
TU + MO1-ptgs1
|
chemical treatment by environment: 16,16-dimethylprostaglandin E2
|
Fig. 4
from Poureetezadi et al., 2016
|
pronephric distal late tubule slc12a3 expression decreased distribution, abnormal
|
TU + MO1-ptgs1
|
standard conditions
|
Fig. 4
from Poureetezadi et al., 2016
|
pronephric duct jag2b expression decreased distribution, abnormal
|
TU + MO1-ptgs1
|
control
|
Fig. 2
from Marra et al., 2019
|
pronephric proximal straight tubule multi-ciliated epithelial cell cimap1b expression decreased distribution, abnormal
|
TU + MO1-ptgs1
|
control
|
Fig. 3
from Marra et al., 2019
|
pronephric distal late tubule decreased size, abnormal
|
TU + MO1-ptgs1
|
standard conditions
|
Fig. 4
from Poureetezadi et al., 2016
|
pronephros has fewer parts of type pronephros multi-ciliated epithelial cell, abnormal
|
TU + MO1-ptgs1
|
standard conditions
|
Fig. 4
from Chambers et al., 2020
|
pronephric duct multi-ciliated epithelial cell has fewer parts of type multi-ciliated epithelial cell cilium, abnormal
|
TU + MO1-ptgs1
|
control
|
Fig. 4
from Marra et al., 2019
|
trunk curved ventral, abnormal
|
TU + MO1-ptgs1
|
standard conditions
|
Fig. 4
from Chambers et al., 2020
|
pronephric distal early tubule slc12a1 expression increased distribution, abnormal
|
TU + MO1-ptgs1
|
standard conditions
|
Fig. 4
from Poureetezadi et al., 2016
|
pronephric proximal convoluted tubule multi-ciliated epithelial cell decreased amount, abnormal
|
TU + MO1-ptgs1
|
control
|
Fig. 3
from Marra et al., 2019
|
pronephric duct multi-ciliated epithelial cell decreased amount, ameliorated
|
TU + MO1-ptgs1
|
chemical treatment by environment: prostaglandin E2
|
Fig. 1
from Marra et al., 2019
|
pronephric duct cimap1b expression decreased distribution, abnormal
|
TU + MO1-ptgs1
|
chemical treatment by environment: prostaglandin E2
|
Fig. 1
from Marra et al., 2019
|
brain hydrocephalic, abnormal
|
TU + MO1-ptgs1
|
control
|
Fig. S3
from Marra et al., 2019
|
pronephric duct pax2a expression decreased distribution, abnormal
|
TU + MO1-ptgs1
|
control
|
Fig. 2
from Marra et al., 2019
|
pronephric duct multi-ciliated epithelial cell decreased amount, abnormal
|
TU + MO1-ptgs1
|
control
|
Fig. 1 ,
Fig. 2
from Marra et al., 2019
|
pericardium edematous, abnormal
|
TU + MO1-ptgs1
|
control
|
Fig. S3
from Marra et al., 2019
|
pronephric distal early tubule slc12a1 expression spatial pattern, ameliorated
|
TU + MO1-ptgs1
|
chemical treatment by environment: 16,16-dimethylprostaglandin E2
|
Fig. 4
from Poureetezadi et al., 2016
|
pronephric duct cimap1b expression decreased distribution, abnormal
|
TU + MO1-ptgs1
|
control
|
Fig. 1
from Marra et al., 2019
|
pronephric distal early tubule increased size, abnormal
|
TU + MO1-ptgs1
|
standard conditions
|
Fig. 4
from Poureetezadi et al., 2016
|
pronephric distal late tubule slc12a3 expression spatial pattern, ameliorated
|
TU + MO1-ptgs1
|
chemical treatment by environment: 16,16-dimethylprostaglandin E2
|
Fig. 4
from Poureetezadi et al., 2016
|
pronephric distal early tubule size, ameliorated
|
TU + MO1-ptgs1
|
chemical treatment by environment: 16,16-dimethylprostaglandin E2
|
Fig. 4
from Poureetezadi et al., 2016
|
brain ventricular system edematous, abnormal
|
WT + MO1-ptgs1
|
standard conditions
|
Fig. 5
from Jin et al., 2014
|
post-vent region curved ventral, abnormal
|
WT + MO1-ptgs1
|
standard conditions
|
Fig. 5
from Jin et al., 2014
|
brain hydrocephalic, abnormal
|
WT + MO1-ptgs1
|
standard conditions
|
Fig. 5
from Jin et al., 2014
|
otic vesicle has extra parts of type otolith, abnormal
|
WT + MO1-ptgs1
|
standard conditions
|
Fig. 5
from Jin et al., 2014
|
heart bilateral symmetry, abnormal
|
WT + MO1-ptgs1
|
standard conditions
|
Fig. 5
from Jin et al., 2014
|
trunk curved ventral, abnormal
|
WT + MO1-ptgs1
|
standard conditions
|
Fig. 5
from Jin et al., 2014
|
Kupffer's vesicle motile cilium decreased length, abnormal
|
WT + MO1-ptgs1
|
standard conditions
|
Fig. 5
from Jin et al., 2014
|
heart looping process quality, abnormal
|
WT + MO1-ptgs1
|
standard conditions
|
Fig. 5
from Jin et al., 2014
|
cilium assembly decreased process quality, abnormal
|
WT + MO1-ptgs1
|
chemical treatment: prostaglandin E2
|
Fig. 5
from Jin et al., 2014
|
Kupffer's vesicle has fewer parts of type Kupffer's vesicle motile cilium, abnormal
|
WT + MO1-ptgs1
|
standard conditions
|
Fig. 5
from Jin et al., 2014
|
lateral crista has fewer parts of type lateral crista kinocilium, abnormal
|
WT + MO1-ptgs1
|
standard conditions
|
Fig. 5
from Jin et al., 2014
|
Kupffer's vesicle has fewer parts of type Kupffer's vesicle motile cilium, abnormal
|
WT + MO1-ptgs1
|
chemical treatment: prostaglandin E2
|
Fig. 5
from Jin et al., 2014
|
cilium assembly decreased process quality, abnormal
|
WT + MO1-ptgs1
|
standard conditions
|
Fig. 5
from Jin et al., 2014
|
exocrine pancreas prss1 expression decreased distribution, abnormal
|
WT + MO1-ptgs1 + MO2-ptgs1
|
control
|
Fig. 2
from Nissim et al., 2014
|
exocrine pancreas size, ameliorated
|
WT + MO1-ptgs1 + MO2-ptgs1
|
chemical treatment: prostaglandin E2
|
Fig. 2
from Nissim et al., 2014
|
hematopoietic stem cell decreased amount, abnormal
|
WT + MO1-ptgs1 + MO2-ptgs1
|
standard conditions
|
Fig. S1
from North et al., 2007
|
exocrine pancreas decreased size, abnormal
|
WT + MO1-ptgs1 + MO2-ptgs1
|
control
|
Fig. 2
from Nissim et al., 2014
|
exocrine pancreas prss1 expression amount, ameliorated
|
WT + MO1-ptgs1 + MO2-ptgs1
|
chemical treatment: prostaglandin E2
|
Fig. 2
from Nissim et al., 2014
|
liver EGFP expression decreased distribution, abnormal
|
as3Tg + MO1-ptgs1 + MO2-ptgs1
|
control
|
Fig. 1
from Nissim et al., 2014
|
liver EGFP expression amount, ameliorated
|
as3Tg + MO1-ptgs1 + MO2-ptgs1
|
chemical treatment: prostaglandin E2
|
Fig. 1
from Nissim et al., 2014
|
liver decreased size, abnormal
|
as3Tg + MO1-ptgs1 + MO2-ptgs1
|
control
|
Fig. 1
from Nissim et al., 2014
|
liver size, ameliorated
|
as3Tg + MO1-ptgs1 + MO2-ptgs1
|
chemical treatment: prostaglandin E2
|
Fig. 1
from Nissim et al., 2014
|
exocrine pancreas decreased size, abnormal
|
zf578Tg + MO1-ptgs1 + MO2-ptgs1
|
control
|
Fig. 2
from Nissim et al., 2014
|
exocrine pancreas size, ameliorated
|
zf578Tg + MO1-ptgs1 + MO2-ptgs1
|
chemical treatment: prostaglandin E2
|
Fig. 2
from Nissim et al., 2014
|
pronephros has fewer parts of type ciliated epithelial cell ciliary basal body, exacerbated
|
TU + MO1-ppargc1a + MO1-ptgs1
|
standard conditions
|
Fig. 4
from Chambers et al., 2020
|
pronephros cilium decreased length, exacerbated
|
TU + MO1-ppargc1a + MO1-ptgs1
|
standard conditions
|
Fig. 4
from Chambers et al., 2020
|
pronephros has number of pronephros multi-ciliated epithelial cell, ameliorated
|
TU + MO1-ppargc1a + MO1-ptgs1
|
chemical treatment by environment: 16,16-dimethylprostaglandin E2
|
Fig. 4
from Chambers et al., 2020
|
trunk curvature, ameliorated
|
TU + MO1-ppargc1a + MO1-ptgs1
|
chemical treatment by environment: 16,16-dimethylprostaglandin E2
|
Fig. 4
from Chambers et al., 2020
|
trunk curved ventral, exacerbated
|
TU + MO1-ppargc1a + MO1-ptgs1
|
standard conditions
|
Fig. 4
from Chambers et al., 2020
|
pronephros cilium assembly process quality, ameliorated
|
TU + MO1-ppargc1a + MO1-ptgs1
|
chemical treatment by environment: 16,16-dimethylprostaglandin E2
|
Fig. 4
from Chambers et al., 2020
|
pronephros cilium assembly decreased process quality, exacerbated
|
TU + MO1-ppargc1a + MO1-ptgs1
|
standard conditions
|
Fig. 4
from Chambers et al., 2020
|
pronephros cilium length, ameliorated
|
TU + MO1-ppargc1a + MO1-ptgs1
|
chemical treatment by environment: 16,16-dimethylprostaglandin E2
|
Fig. 4
from Chambers et al., 2020
|
pronephric distal late tubule slc12a3 expression decreased distribution, abnormal
|
TU + MO1-ptger2a + MO1-ptgs1
|
standard conditions
|
Fig. 4
from Poureetezadi et al., 2016
|
pronephric distal late tubule decreased size, abnormal
|
TU + MO1-ptger2a + MO1-ptgs1
|
standard conditions
|
Fig. 4
from Poureetezadi et al., 2016
|
pronephric distal early tubule slc12a1 expression increased distribution, abnormal
|
TU + MO1-ptger2a + MO1-ptgs1
|
standard conditions
|
Fig. 4
from Poureetezadi et al., 2016
|
pronephric distal early tubule increased size, abnormal
|
TU + MO1-ptger2a + MO1-ptgs1
|
standard conditions
|
Fig. 4
from Poureetezadi et al., 2016
|
pronephric duct jag2b expression decreased distribution, abnormal
|
TU + MO1-ptgs1 + MO1-ptgs2a
|
control
|
Fig. 2
from Marra et al., 2019
|
pronephric duct multi-ciliated epithelial cell has fewer parts of type multi-ciliated epithelial cell cilium, abnormal
|
TU + MO1-ptgs1 + MO1-ptgs2a
|
control
|
Fig. 4
from Marra et al., 2019
|
pericardium edematous, abnormal
|
TU + MO1-ptgs1 + MO1-ptgs2a
|
control
|
Fig. S3
from Marra et al., 2019
|
pronephric duct multi-ciliated epithelial cell decreased amount, exacerbated
|
TU + MO1-ptgs1 + MO1-ptgs2a
|
control
|
Fig. 2
from Marra et al., 2019
|
pronephric duct multi-ciliated epithelial cell decreased amount, ameliorated
|
TU + MO1-ptgs1 + MO1-ptgs2a
|
chemical treatment by environment: prostaglandin E2
|
Fig. 1
from Marra et al., 2019
|
pronephric duct pax2a expression decreased distribution, abnormal
|
TU + MO1-ptgs1 + MO1-ptgs2a
|
control
|
Fig. 2
from Marra et al., 2019
|
pronephric duct cimap1b expression decreased distribution, abnormal
|
TU + MO1-ptgs1 + MO1-ptgs2a
|
chemical treatment by environment: prostaglandin E2
|
Fig. 1
from Marra et al., 2019
|
brain hydrocephalic, abnormal
|
TU + MO1-ptgs1 + MO1-ptgs2a
|
control
|
Fig. S3
from Marra et al., 2019
|
pronephric duct cimap1b expression decreased distribution, abnormal
|
TU + MO1-ptgs1 + MO1-ptgs2a
|
control
|
Fig. 1
from Marra et al., 2019
|
pronephric proximal convoluted tubule multi-ciliated epithelial cell decreased amount, abnormal
|
TU + MO1-ptgs1 + MO1-ptgs2a
|
control
|
Fig. 3
from Marra et al., 2019
|
pronephric proximal straight tubule multi-ciliated epithelial cell cimap1b expression decreased distribution, abnormal
|
TU + MO1-ptgs1 + MO1-ptgs2a
|
control
|
Fig. 3
from Marra et al., 2019
|
pronephric duct multi-ciliated epithelial cell decreased amount, abnormal
|
TU + MO1-ptgs1 + MO1-ptgs2a
|
control
|
Fig. 1
from Marra et al., 2019
|
brain ventricular system edematous, abnormal
|
WT + MO1-ptgs1 + MO2-ptgs2a
|
standard conditions
|
Fig. 5
from Jin et al., 2014
|